1. "Jose Baselga"
Formats
  1. Meeting Abstract (241)
  2. Journal Article (232)
  3. Conference Paper (4)
  4. Research Letter (3)
  5. Book Section (2)
  6. Review (1)
Groups
  1. Department of Medicine (196)
  2. Solid Tumor Oncology Division (191)
  3. Breast Medicine Service (149)
  4. GSK Faculty (127)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (108)
  6. Human Oncology and Pathogenesis Program (105)

More Groups

People
  1. Jose Baselga (483)
  2. David Hyman (67)
  3. Maurizio Scaltriti (63)
  4. Clifford Hudis (57)
  5. Michael Berger (56)
  6. Larry Norton (51)

More People

Years
  1. 2021 (5)
  2. 2020 (11)
  3. 2019 (25)
  4. 2018 (58)
  5. 2017 (67)
  6. 2016 (67)

More Years

Publications
  1. Cancer Research (109)
  2. Journal of Clinical Oncology (92)
  3. Annals of Oncology (29)
  4. Clinical Cancer Research (29)
  5. European Journal of Cancer (25)
  6. Cancer Discovery (13)

More Publications

Publishers
  1. American Association for Cancer Research (163)
  2. American Society of Clinical Oncology (96)
  3. Oxford University Press (41)
  4. Elsevier Inc. (39)
  5. Nature Publishing Group (30)
  6. Springer (16)

More Publishers

Results (483)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • BRCA-mediated tumorigenesis is origin and cell-type dependent
    Meeting Abstract

    Jonsson, P.; Cheng, M. L.; Bandlamudi, C.; Srinivasan, P.; Chavan, S. S.; Friedman, N. D.; Rosen, E. Y.; Richards, A. L.; Bouvier, N.; Selcuklu, S. D.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • PI3K pathway mediated splicing defects in ER+ breast cancers
    Meeting Abstract

    Ladewig, E.; Fairchild, L.; Scaltriti, M.; Leslie, C.; Toska, E.; Baselga, J.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Molecular screening of patients with FGFR alterations for phase 1 (ph1) study with the selective FGFR inhibitor Debio 1347
    Meeting Abstract

    Iafrate, A. J.; Borger, D. R.; Vivancos, A.; Voss, M.; Cleary, J.; Meric-Bernstam, F.; Tabernero, J.; Flaherty, K.; Ishii, N.; Brichory, F.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Non-canonical, clinical ESR1 mutations promote resistance to antiestrogen therapies
    Meeting Abstract

    Toy, W.; Carlson, K. E.; Martin, T. A.; Razavi, P.; Berger, M.; Baselga, J.; Greene, G.; Katzenellenbogen, J.; Chandarlapaty, S.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Phase Ib/II study of capecitabine 7/7 schedule with neratinib in patients with HER2-positive metastatic breast cancer (MBC)
    Meeting Abstract

    Wang, R.; Singh, J.; Sterlin, V.; Goldstein, M.; Lake, D.; Wong, S.; Baselga, J.; Norton, L.; Dang, C.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Exploratory biomarker analyses of FAIRLANE, a double-blind placebo (PBO)-controlled randomized phase II trial of neoadjuvant ipatasertib (IPAT) plus paclitaxel (PAC) for early triple-negative breast cancer (TNBC)
    Meeting Abstract

    Wongchenko, M. J.; Oliveira, M.; Saura, C.; Nuciforo, P.; Calvo, I.; Andersen, J.; Coelho, J. I. P.; Gil, M. G.; Bermejo, B.; Patt, D. A.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Dose justification for DS-8201a, a HER2-targeted antibody-drug conjugate, for HER2-positive breast cancer: Observed clinical data and exposure-response analyses
    Meeting Abstract

    Tamura, K.; Modi, S.; Tsurutani, J.; Takahashi, S.; Krop, I. E.; Iwata, H.; Wada, R.; Yin, O.; Garimella, T.; Sugihara, M.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Everolimus plus exemestane for hormone receptor-positive advanced breast cancer: A PAM50 intrinsic subtype analysis of BOLERO-2
    Journal Article

    Prat, A.; Brase, J. C.; Cheng, Y.; Nuciforo, P.; Paré, L.; Pascual, T.; Martínez, D.; Galván, P.; Vidal, M.; Adamo, B.; more...
    The Oncologist (2019)

    Fulltext@MSK | Save
  • Tumour lineage shapes BRCA-mediated phenotypes
    Research Letter

    Jonsson, P.; Bandlamudi, C.; Cheng, M. L.; Srinivasan, P.; Chavan, S. S.; Friedman, N. D.; Rosen, E. Y.; Richards, A. L.; Bouvier, N.; Selcuklu, S. D.; more...
    Nature (2019)

    Fulltext@MSK | Save
  • Circulating tumor DNA in HER2-amplified breast cancer: A translational research substudy of the NeoALTTO Phase III Trial
    Journal Article

    Rothé, F.; Silva, M. J.; Venet, D.; Campbell, C.; Bradburry, I.; Rouas, G.; De Azambuja, E.; Maetens, M.; Fumagalli, D.; Rodrik-Outmezguine, V.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save